0001662119-22-000002.txt : 20220706 0001662119-22-000002.hdr.sgml : 20220706 20220706161606 ACCESSION NUMBER: 0001662119-22-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220705 FILED AS OF DATE: 20220706 DATE AS OF CHANGE: 20220706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amado Rafael CENTRAL INDEX KEY: 0001662119 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 221068889 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-07-05 0 0001737287 Allogene Therapeutics, Inc. ALLO 0001662119 Amado Rafael 210 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP of R&D and CMO Common Stock 2022-07-05 4 S 0 2000 11.44 D 542257 D 1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022. Veer Bhavnagri as attorney-in-fact for Rafael Amado 2022-07-06